Searchable abstracts of presentations at key conferences in endocrinology

ea0090p298 | Calcium and Bone | ECE2023

Localization studies in 443 patients with primary hyperparathyroidism by using a stepwise approach

Balcı Gulşah , Begum Bahcecioglu Mutlu Adile , Avcı Merdin Fatma , Erdogan Murat

Objective: Primary hyperparathyroidism (PHP) is a common endocrine disorder diagnosed biochemically, common use of autoanalyzers increased the incidence of PHP throughout last decades. Minimally invasive parathyroidectomy has been preferred to the explorative surgical approach due to shorter operating time, lower complication rate, and smaller incision size. Thus localization studies have become very important. We aimed to investigate clinical and laboratory characteristics of...

ea0090p502 | Thyroid | ECE2023

Long-Term Effects of Radioiodine Treatment on Thyroid Functions, Thyroid Volume, Nodule Volume and Ultrasonographic Features in Patients with Toxic Adenoma and Toxic Multinodular Goitre

Koc Ilgın , Begum Bahcecioglu Mutlu Adile , Avcı Merdin Fatma , Araz Mine , Erdogan Murat

Background: Radioiodine(RAI) has been used to treat hyperthyroidism for more than seven decades. Effects of RAI treatment on thyroid function tests(TFT), risk of hypothyroidism, gland and autonomous nodule volumes and on ultrasonographic features in toxic adenoma (TA) and toxic multinodular goitre TMNG patients, have been previously studied by ourselves and other. However, studies evaluating ultrasonographic changes in thyroid and toxic nodule volumes usually have a follow-up ...

ea0090p791 | Thyroid | ECE2023

Long-Term Effects of Radioiodine Treatment on Parathyroid Gland Functions in Patients with Benign or Malignant Thyroid Diseases

Avcı Merdin Fatma , Corapcıoğlu Demet , Sahin Mustafa

Background: Radioiodine (RAI) therapy has been used for a long time in benign and malign diseases of the thyroid gland. During the application of radioiodine treatment, parathyroid glands may also be exposed to radiation due to its close proximity to the thyroid gland. There is interest in the effects of RAI treatment on parathyroid functions in clinical studies. The aim of this study is to evaluate whether the dose of RAI treatment for benign or malignant thyroid diseases has...

ea0092ps3-22-08 | Nodules 2 | ETA2023

Natural course of benign thyroid nodular disease in a borderline iodine-sufficient area: 10-year retrospective follow-up data from a tertiary center

Erdogan Murat , Bahcecioglu Begum , Avcı Merdin Fatma , Emral Rifat , Halil Elhan Atilla , Gullu Sevim

Objective: Thyroid nodules are common in the population more than 90% are benign. Data about the long-term follow-up of benign nodular thyroid disease is limited. We aimed to clarify, clinical outcome, frequency and magnitude of volume changes in cytologically and/or sonographically benign nodules in long-term(> 5 years) follow-up and to determine the predictive features of nodule growth.Methods: We retrospectively collected data of cytologically and...

ea0090ep19 | Adrenal and Cardiovascular Endocrinology | ECE2023

21-hydroxylase deficient congenital adrenal hyperplasia in adult endocrinology clinics of turkey: A nationwide multicenter study

Ertorer Melek Eda , Anaforoglu İnan , Yilmaz Nusret , Akkus Gamze , Turgut Seda , Unluhizarci Kursad , Selcukbiricik Ozlem Soyluk , Merdin Fatma Avcı , Karakilic Ersen , Pehlivan Esma , Yorulmaz Goknur , Gul Ozen Oz , Emral Rifat , Kebapci Medine Nur , Acubucu Fettah , Tuzun Dilek , Gorar Suheyla , Topuz Emek , Bagir Gulay Simsek , Genc Selin , Demir Kezban , Tamer Gonca , Yaylali Guzin , Omma Tulay , Firat Sevde Nur , Koc Gonul , Saygili Emre Sedar , Yurekli Banu Sarer

Introduction: Congenital adrenal hyperplasia (CAH) is a group of autosomal recessively inherited disorders that are characterised by inactivating mutations at various steps of adrenal steroidogenic pathways causing defective cortisol biosynthesis. 21-Hydroxylase enzyme deficiency (21-OHd) constitutes more than 95% of all CAH cases.Material & Methods: Medical records of patients with all forms of CAH from 19 adult endocrinology clinics located at six ...